(85 days)
Not Found
No
The device description and performance studies focus on mechanical dilation and procedural success rates, with no mention of AI or ML technologies.
Yes
The device is used to access and treat sinus ostia and infundibula by remodeling bony sinus outflow tracts through balloon displacement, which is a therapeutic intervention.
No
The device description and intended use clearly state that the XprESS Multi-Sinus Dilation System is used for treating (remodeling bony sinus outflow tracts by balloon displacement) rather than diagnosing.
No
The device description explicitly lists multiple hardware components included in the system, such as the XprESS device, Inflation Syringe, Bending Tool, Extension Lines, PathAssist LED Light Fiber, and Tuohy Adapter.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The description clearly states that the XprESS Multi-Sinus Dilation System is used to physically access and treat sinus ostia and recesses by balloon dilation. This is a surgical or procedural device used directly on the patient's anatomy.
- Lack of Sample Analysis: There is no mention of the device being used to analyze any biological samples.
Therefore, the XprESS Multi-Sinus Dilation System falls under the category of a therapeutic or surgical device, not an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
To access and treat the maxillary ostia/ethmoid infundibula in patients 2 years and older, and frontal ostia/recesses and sphenoid sinus ostia in patients 12 years and older using a trans-nasal approach. The bony sinus outflow tracts are remodeled by balloon displacement of adjacent bone and paranasal sinus structures.
Product codes
LRC
Device Description
The XprESS Multi-Sinus Dilation System is intended to recreate the sinus outflow tract via trans-nasal balloon dilation. The XprESS device combines features of a curved suction tip and a frontal ostium seeker with the tissue expansion effect of balloon dilation. The familiar features of this device enable a physician to track the device to the sinus ostium using endoscopic visualization. Since the distal end of the device is re-shapeable, one balloon can be modified to work on multiple sinuses within the same patient.
The XprESS curved suction tip has an atraumatic ball tip. A suction tube may be connected to the proximal barbed fitting to provide active suction by covering the suction vent. An Extension Line connected to a syringe may be connected to the proximal barbed fitting to provide irrigation. The device was designed to prevent fluid from exiting the suction vent during irrigation. The XprESS Multi-Sinus Dilation System is provided sterile and for single use only.
The Xpress Multi-Sinus Dilation System includes the XprESS device, Inflation Syringe, Bending Tool and two Extension Lines. The XprESS LoProfile and Ultra Multi-Sinus Dilation Systems also include the PathAssist LED Light Fiber. The XprESS Pro Multi-Sinus Dilation System also includes a Tuohy Adapter.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
maxillary ostia/ethmoid infundibula, frontal ostia/recesses, sphenoid sinus ostia, paranasal sinus structures
Indicated Patient Age Range
2 years and older (maxillary ostia/ethmoid infundibula), 12 years and older (frontal ostia/recesses and sphenoid sinus ostia)
Intended User / Care Setting
physician / Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing of the XprESS device consisted of clinical testing to support the expanded indications for use. A prospective, multicenter, single-arm study investigating the use of XprESS in patients aged 2-21 years was conducted in the United States under IDE G140080. The primary outcome measures were procedural technical success rate and complication rate. A total of 157 sinus dilations were attempted in 50 subjects. All 157 attempts were successfully completed for an overall XprESS technical success rate of 100%. No complications (0%) were reported during the study. In addition, no adverse events related to the device or the balloon dilation procedure were reported during the study. Performance testing showed that the device performed as intended.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Technical success rate: 100%, Complication rate: 0%
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 874.4420 Ear, nose, and throat manual surgical instrument.
(a)
Identification. An ear, nose, and throat manual surgical instrument is one of a variety of devices intended for use in surgical procedures to examine or treat the bronchus, esophagus, trachea, larynx, pharynx, nasal and paranasal sinus, or ear. This generic type of device includes the esophageal dilator; tracheal bistour (a long, narrow surgical knife); tracheal dilator; tracheal hook; laryngeal injection set; laryngeal knife; laryngeal saw; laryngeal trocar; laryngectomy tube; adenoid curette; adenotome; metal tongue depressor; mouth gag; oral screw; salpingeal curette; tonsillectome; tonsil guillotine; tonsil screw; tonsil snare; tonsil suction tube; tonsil suturing hook; antom reforator; ethmoid curette; frontal sinus-rasp; nasal curette; nasal rasp; nasal rongeur; nasal saw; nasal scissors; nasal snare; sinus irrigator; sinus trephine; ear curette; ear excavator; ear rasp; ear scissor, ear snare; ear spoon; ear suction tube; malleous ripper; mastoid gauge; microsurgical ear chisel; myringotomy tube inserter; ossici holding clamp; sacculotomy tack inserter; vein press; wire ear loop; microrule; mirror; mobilizer; ear, nose, and throat punch; ear, nose and throat knife; and ear, nose, and throat trocar.(b)
Classification Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 874.9.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract symbol that resembles an eagle or a bird in flight, composed of three stylized human profiles facing to the right.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
November 20, 2015
Entellus Medical, Inc. Ms. Karen Peterson Vice President, Clinical, Regulatory and Quality 3600 Holly Lane North. Suite 40 Plymouth, MN 55447
Re: K152434
Trade/Device Name: XprESS Multi-Sinus Dilation System Regulation Number: 21 CFR 874.4420 Regulation Name: Ear, Nose, and Throat Manual Surgical Instrument Regulatory Class: Class I Product Code: LRC Dated: October 27, 2015 Received: October 28, 2015
Dear Ms. Peterson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Eric A. Mann -S
for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K152434
Device Name XprESS Multi-Sinus Dilation System
Indications for Use (Describe)
To access and treat the maxillary ostia/ethmoid infundibula in patients 2 years and older, and frontal ostia/recesses and sphenoid sinus ostia in patients 12 years and older using a trans-nasal approach. The bony sinus outflow tracts are remodeled by balloon displacement of adjacent bone and paranasal sinus structures.
Type of Use (Select one or both, as applicable)
2 Prescription Use (Part 21 CFR 801 Subpart D)
_ Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
FOR FDA USE ONLY
Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for "entellus MEDICAL". To the left of the company name is a circular graphic made up of blue and black curved shapes. The company name is in black font, with the word "entellus" on top of the word "MEDICAL", which is in a smaller font size.
510(k) Summary
Date Prepared: Submitter Information: August 26, 2015 Entellus Medical, Inc. 3600 Holly Lane North, Suite 40 Plymouth, MN 55447
Establishment Registration:
Contact Information:
Device Information: Trade Name: Common Name: Classification Name: Product Code: Regulation Number: 3006345872
Karen E. Peterson Vice President Clinical, Regulatory and Quality (763) 463-7066 kpeterson@entellusmedical.com
XprESS Multi-Sinus Dilation System [K142252]
XprESS Multi-Sinus Dilation System Balloon Sinus Dilation System ENT Manual Surgical Instrument LRC Class I, 21 CFR 874.4420
Predicate Device:
Device Description:
The XprESS Multi-Sinus Dilation System is intended to recreate the sinus outflow tract via trans-nasal balloon dilation. The XprESS device combines features of a curved suction tip and a frontal ostium seeker with the tissue expansion effect of balloon dilation. The familiar features of this device enable a physician to track the device to the sinus ostium using endoscopic visualization. Since the distal end of the device is re-shapeable, one balloon can be modified to work on multiple sinuses within the same patient.
Image /page/3/Figure/13 description: This image shows a medical device with several labeled parts. The device has a long, thin body with a curved suction tip at one end. A balloon slide mechanism is located along the body of the device. At the opposite end, there is a proximal barbed fitting and a balloon inflation luer.
XprESS Multi-Sinus Dilation Device
The XprESS curved suction tip has an atraumatic ball tip. A suction tube may be connected to the proximal barbed fitting to provide active suction by covering the suction vent. An Extension Line connected to a syringe may be connected to the proximal barbed fitting to provide irrigation. The device was designed to prevent fluid from exiting the suction vent during irrigation. The XprESS Multi-Sinus Dilation System is provided sterile and for single use only.
The Xpress Multi-Sinus Dilation System includes the XprESS device, Inflation Syringe, Bending Tool and two Extension Lines. The XprESS LoProfile and Ultra Multi-Sinus Dilation Systems also include the PathAssist LED Light Fiber. The XprESS Pro Multi-Sinus Dilation System also includes a Tuohy Adapter.
4
XprESS is available in the following suction tip sizes and balloon sizes. All suction tips and balloon lengths are appropriate for treating all sinuses; selection is based on physician preference.
| XprESS Pro | XprESS LoProfile | XprESS Ultra |
|---|---|---|
| Standard Suction Tip | LoProfile Suction Tip | Ultra Suction Tip |
| (2mm ball tip, 1mm ID, 1.5mm OD) | (1.75mm ball tip, 0.7mm ID, .2mm OD) | (1.5mm ball tip, 0.5mm ID, 1.0mm OD) |
| Balloon Diameter x Length (mm) | Balloon Diameter x Length (mm) | Balloon Diameter x Length (mm) |
| NA | 5 x 8 | 5 x 8 |
| 5 x 18 | 5 x 18 | 5 x 20 |
| 6 x 8 | 6 x 8 | 6 x 8 |
| 6 x 18 | 6 x 18 | 6 x 20 |
| 7 x 18 | 7 x 18 | NA |
The XprESS Multi-Sinus Dilation System has been tested to withstand multiple inflations and device tip manipulations in a surgical case wherein all 6 sinus ostia are being dilated.
Indication for Use:
To access and treat the maxillary ostia/ethmoid infundibula in patients 2 years and older, and frontal ostia/recesses and sphenoid sinus ostia in patients 12 years and older using a trans-nasal approach. The bony sinus outflow tracts are remodeled by balloon displacement of adjacent bone and paranasal sinus structures.
Contraindications:
None known.
Technological Characteristics:
The XprESS device has expanded indications for use, identical intended use, and identical scientific technology (i.e., principle of operation, design, function, materials, biocompatibility, packaging, shelf life, and sterilization) as the predicate device.
Substantial Equivalence:
The XprESS device has expanded indications for use, identical intended use, and identical fundamental scientific technology as the predicate device. The XprESS device is substantially equivalent to the predicate device.
Performance Data:
Performance testing of the XprESS device consisted of clinical testing to support the expanded indications for use. A prospective, multicenter, single-arm study investigating the use of XprESS in patients aged 2-21 years was conducted in the United States under IDE G140080. The primary outcome measures were procedural technical success rate and complication rate. A total of 157 sinus dilations were attempted in 50 subjects. All 157 attempts were successfully completed for an overall XprESS technical success rate of 100%. No complications (0%) were reported during the study. In addition, no adverse events related to the device or the balloon dilation procedure were reported during the study. Performance testing showed that the device performed as intended.
Conclusion:
In conclusion, the technological characteristics are identical the predicate device. Performance testing has demonstrated that the device is safe and effective and that its performance is substantially equivalent to the predicate device.